Search

everythinglearnresearchcommunity

for

Search:↓

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

LLLT promotes hair growth and improves hair density safely in men and women.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Human leukocytes and beard hair follicle cells have internal daily clocks, and PER1 and PER3 genes may indicate individual circadian rhythms.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Rats had lasting erectile problems after stopping a certain medication.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

The normal human prostate does not significantly affect blood DHT levels.